Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by John D. Clemens
Randomized, Controlled Study of the Safety and Immunogenicity of Peru‐15, a Live Attenuated Oral Vaccine Candidate for Cholera, in Adult Volunteers in Bangladesh
Journal of Infectious Diseases
Infectious Diseases
Allergy
Immunology
Related publications
Evaluation in Volunteers of a Candidate Live Oral Attenuated Salmonella Typhi Vector Vaccine.
Journal of Clinical Investigation
Medicine
Safety and Immunogenicity of a Live Attenuated Mumps Vaccine
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus Naive Children
American Journal of Tropical Medicine and Hygiene
Medicine
Virology
Parasitology
Infectious Diseases
Safety and Immunogenicity of a Live-Attenuated Junin (Argentine Hemorrhagic Fever) Vaccine in Rhesus Macaques
American Journal of Tropical Medicine and Hygiene
Medicine
Virology
Parasitology
Infectious Diseases
Safety and Immunogenicity of Different Immunization Regimens of CVD 103-HgR Live Oral Cholera Vaccine in Soldiers and Civilians in Thailand
Journal of Infectious Diseases
Infectious Diseases
Allergy
Immunology
Extended Preclinical Safety, Efficacy and Stability Testing of a Live-Attenuated Chikungunya Vaccine Candidate
PLoS Neglected Tropical Diseases
Pharmacology
Public Health
Environmental
Toxicology
Infectious Diseases
Pharmaceutics
Occupational Health
Immunogenicity and Reactogenicity of Francisella Tularensis Strain 15/23-1 recA - The Candidate for a New Live Tularemia Vaccine
Epidemiology and Vaccine Prevention
A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico
American Journal of Tropical Medicine and Hygiene
Medicine
Virology
Parasitology
Infectious Diseases
Comparative Randomized Study of Tolerability, Reactogenicity, Immunogenicity and Safety of the Vaccine «BiVac Polio» (Oral Poliovirus Vaccine Type 1,3)
Epidemiology and Vaccine Prevention